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Abstract
Background Whereas specimen radiography (SR) is an
established strategy for intraoperative resection margin
analysis during breast-conserving surgery for nonpalpable
lesions, the use of frozen section analysis (FSA) is still a
matter of debate.
Methods A retrospective review was conducted of 115
consecutive operations in which the two objectives sought
were the excision of nonpalpable malignant lesions and
breast conservation. Breast surgery was performed in the
Gynecology and the Surgery Departments at the Basel
University Hospital Breast Center. Whereas one depart-
ment preferably uses SR for intraoperative margin
assessments of lesions involving ductal carcinoma in situ
(DCIS) or atypical ductal hyperplasia, the other uses FSA
to increase the rate of complete removal of these lesions
with a single procedure. The respective accuracy and
therapeutic impact of these two techniques are compared
here.
Results Intraoperative resection margin assessments were
performed with FSA in 80 and SR in 35 of a total of 115
operations performed on 111 patients with pTis, pT1, or
pT2 nonpalpable breast cancer. FSA diagnostic accuracy,
sensitivity, and specificity were 83.8%, 80.0%, and 87.5%,
respectively, compared to 60%, 60%, and 60%, respec-
tively, for SR. FSA tended to have a stronger therapeutic
impact than SR in terms of the number of patients in whom
initially positive margins were rendered margin-negative
thanks to intraoperative analysis and immediate reexcision
or mastectomy (27.5% vs. 14.3%; p = 0.124). More
importantly, significantly fewer secondary reexcisions
were performed in the FSA series than in the SR series
(12.5% vs. 37.1%; p = 0.002). Finally, the intraoperative
detection of invasive cancer with FSA led to a significantly
lower number of secondary procedures for axillary lymph
node staging (5% vs. 25.7%; p = 0.001).
Conclusions The present results suggest that FSA may be
more accurate than SR for analyzing intraoperative resec-
tion margins during breast-conserving surgery for
nonpalpable lesions.
Introduction
Large prospective randomized trials have shown that
breast-conserving surgery (BCS) followed by irradiation is
equally as effective as radical mastectomy when treating
breast cancer [1–5]. Widespread mammographic screening
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and the concomitant detection of a growing proportion of
early invasive breast cancer and ductal carcinoma in situ
(DCIS) have led to a higher percentage of patients quali-
fying for BCS [6, 7]. Various stereotactically and
sonographically guided biopsy techniques have been
established for such breast lesions, which are frequently
nonpalpable [8]. Although surgical margin analysis has
been acknowledged to be a critical component of BCS, the
best assessment technique has yet to be determined.
Historically, specimen radiography (SR) has been used
to confirm that a nonpalpable radiopaque breast lesion has
been removed, and resection margin status has been
determined solely on the basis of permanent section anal-
ysis [9–11]. In the meantime, SR has become an accepted
strategy for evaluating the completeness of resection of
nonpalpable breast lesions, particularly DCIS [12–14].
The use of frozen section analysis (FSA) has not been
recommended because of several limitations [15]. None-
theless, the few published studies that have addressed the
accuracy of FSA assessments of breast cancer specimen
margins have reported encouraging results [16–19]. These
studies, however, have not focused on nonpalpable breast
lesions.
At Basel University Hospital, breast cancer surgery is
performed in the gynecology and the surgery departments.
One department preferably uses SR and the other uses FSA
to increase the rate of complete removal of lesions
involving DCIS or atypical ductal hyperplasia in a single
procedure. In the present study, BCS performed on patients
with nonpalpable breast lesions was evaluated retrospec-
tively to test the hypothesis that FSA yields better results
than SR in terms of accuracy and therapeutic impact for the
intraoperative assessment of resection margin status.
Materials and methods
Patients
A retrospective medical chart review was performed on
patients treated for nonpalpable breast lesions at Basel
University Hospital between January 1990 and December
2004. Only women whose intended treatment was BCS
were included. Patients and procedures in which the
lumpectomy was monitored for completeness of excision
solely by permanent section analysis were excluded. The
following variables were recorded in an Excel file
(Microsoft, Redmond, WA, USA): patient demographics;
methods used to diagnose and localize the lesion for
excision; therapeutic procedures in detail; and clinical and
pathological features among others. The 6th edition of the
American Joint Committee on Cancer (AJCC) cancer
staging system was used for staging [20].
Surgical therapy and resection margin analysis
Breast surgery was performed in two departments at the
Basel University Hospital Breast Center. In most cases
where the preoperative biopsy detected invasive cancer
only, both departments used FSA for intraoperative margin
assessment. If the preoperative biopsy revealed DCIS or
atypical ductal hyperplasia or if the only preoperative
information available was a cytologic analysis, however, in
one department the margin status was evaluated intraop-
eratively with SR and in the other with FSA. All
mammograms were routinely discussed with the radiologist
before surgery and kept at hand in the operating room until
they were sent to the radiology department together with
the breast specimen. During surgery there was a close
collaboration between the surgical team, radiologists, and
pathologists.
Specimen radiography
Specimen radiography consisted in full-field digital mam-
mography performed with a Hologic ‘‘Selenia’’ imager.
Most commonly, manual exposures were obtained with a
molybdanium filter at exposure settings of 20 kV and 25
mAs. Images were routinely obtained at a magnification of
1.89. At least two orthogonal planes were imaged. SR
images were then compared to the preoperative mam-
mography results.
In the one lesion that was not visible on the mammo-
gram, sonography alone was used for initial detection, wire
localization, and specimen radiography. Sonograms were
obtained with a Philips HDI 5000 system fitted with a 12-
mHz linear transducer.
When the resection margin found by SR or sonogram
imaging was \1 cm wide, the specimen was classified as
positive and reexcision was recommended.
Frozen section analysis
Frozen section analysis was performed depending on the
gross pathology examination results and the pathologist’s
reply to the surgeon’s question. Surgeons routinely ori-
ented the breast tissue with sutures and sent the specimen
intact to the Pathology Department. Multicolor inking was
used to mark the surfaces of the specimen. If a tumor mass
was palpable ex vivo, the specimen was sliced in 3- to 5-
mm sections perpendicular to the long axis. Margins were
grossly examined for proximity to the tumor, and frozen
sections were prepared of the ones located closest to the
cancerous tissue for examination. Where there was no
palpable ex vivo tumor and no grossly visible mass lesion,
FSA was performed on breast tissue shaved circumferen-
tially off the lumpectomy cavity or, if technically feasible,
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on all the resection margins. Margins with tumors within a
1-mm band were regarded as positive.
If the radiologist or pathologist reported that the resec-
tion was incomplete, reexcisions and intraoperative margin
analyses were immediately performed until negative mar-
gins could be obtained via BCS or mastectomy (if the latter
had been discussed with the patient preoperatively).
Permanent section analysis
All frozen sections were also examined in permanent par-
affin-embedded sections for quality control and assurance.
In all cases, additional permanent sections of the specimen
were analyzed. When microcalcifications were present,
permanent sections of the entire specimen were usually
prepared and evaluated. A negative surgical margin was
defined to be a margin free of tumor cells or atypical ductal
hyperplasia for C1 mm, whereas a positive margin was
defined as containing tumor within 1 mm.
Axillary lymph node staging was included in the pri-
mary operation protocol for all patients with breast lesions
containing invasive cancer and some patients with a large
DCIS. If FSA identified a previously undetected invasive
component, axillary staging was performed immediately or
subsequently depending on the existence of the patient’s
informed consent. The sentinel lymph node procedure for
axillary staging was introduced at Basel University Hos-
pital in 1997. Prior to that year, and in case of positive
sentinel lymph nodes, patients were treated by level I and II
axillary lymph node dissection.
Interdisciplinary commissions
All patients treated for breast cancer were discussed at
interdisciplinary meetings. When permanent section anal-
ysis determined surgical margins to be positive, secondary
reexcision or mastectomy was recommended. When a
previously unidentified invasive component was detected,
the possibility of further surgery for axillary staging was
considered. Finally, specific adjuvant therapy and a follow-
up strategy were designed for each patient at these meet-
ings, in keeping with existing guidelines.
Statistical analysis
The chi-squared test was used to compare categorical
variables, and the Mann-Whitney U-test was used to
compare continuous variables. All tests were two-tailed.
The significance level was defined as p \ 0.05. The tests
were run with SPSS Version 13.0 for Macintosh (SPSS,
Chicago, IL, USA). Diagnostic accuracy, sensitivity,
specificity, and the negative and positive predictive values
were calculated as described elsewhere [21].
Results
The study population consisted of 115 nonpalpable, histo-
logically or cytologically malignant breast lesions in 111
women in whom BCS was attempted. In 80 procedures,
surgical resection margin status was determined intraop-
eratively via FSA; in 35, the intraoperative margin was
assessed with SR. In one procedure SR was performed with
US techniques alone (i.e., without mammography) because
the lesion was mammographically imperceptible. Patients’
baseline characteristics as determined by intraoperative
resection margin analysis are given in Table 1.
Final histopathology, treatment, and follow-up
The final histopathologic findings, respective tumor stages,
treatment, and follow-up are given in Table 2. As expected,
none of the nonpalpable breast lesions exceeded primary
tumor stage pT2. In all, 19 cases of invasive cancer not
histologically confirmed prior to the operation were
detected by FSA.
A full long-term follow-up data set was built for 103 of
these 115 procedures (89.6%) (Table 2). Of the six patients
with recurrent lesions, two had had a positive resection
margin after the first excision.
Accuracy and therapeutic impact of FSA and SR
The results of intraoperative margin analysis and the
respective accuracy rates after the first operation are shown
by analytic technique in Table 3. The accuracy rates were
consistently higher for FSA than SR. More importantly,
there was a statistical trend toward a stronger therapeutic
impact of FSA than SR: 27.5% of patients in the FSA series
were rendered margin-negative by intraoperative analysis
and immediate reexcision or mastectomy compared to only
14.3% in the SR series (p = 0.124). This clinically relevant
trend was even more pronounced in the subgroup of pro-
cedures performed for DCIS or atypical ductal hyperplasia
(29.8% vs. 12.9%; p = 0.083). FSA was performed in 33
of the 37 operations involving lesions whose preoperative
biopsy indicated invasive cancer only. In this group, the
diagnostic accuracy, sensitivity, and specificity of FSA
were 81.8%, 75.0%, and 85.7%, respectively; and 8
patients (24.2%) with initially positive margins were suc-
cessfully rendered margin-negative during the primary
operation.
Table 4 shows the main findings of the present study. In
the FSA series, axillary staging was performed signifi-
cantly less frequently with a secondary procedure. More
importantly, FSA yielded significantly lower rates of sec-
ondary reexcisions than SR (12.5% vs. 37.1%, p = 0.002).
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Discussion
The use of FSA in connection with the complete removal
of nonpalpable breast lesions in a single procedure is a
matter of debate. To the authors’ knowledge, this is the first
study to focus on the accuracy and therapeutic impact of
FSA versus intraoperative SR in this setting. The current
findings suggest that FSA is a better tool than SR for
reducing the need for secondary operations. Although the
tendency for FSA to have a stronger therapeutic impact
than SR was not statistically significant due to the small
sample size, this trend is highly relevant from a clinical
standpoint. Significantly fewer secondary reexcisions were
performed in the FSA series than in the SR series. How-
ever, this was due partially to the fact that 12 of 33 patients
(36.4%) with positive margins after the primary operation
underwent no further local surgery to obtain margin-neg-
ative tissue (9 in the FSA group, 3 in the SR group). Two
patients refused any further surgery; and in two, whose
pectoral fascia had been excised, the positive margin was
oriented toward the pectoral muscle. In the remaining 8
cases (all elderly women who were actively involved in the
decision-making process), the interdisciplinary consensus
was that systematic adjuvant treatment alone would suffice,
thereby sparing these patients further surgery. Finally,
significantly fewer secondary axillary lymph node staging
procedures were needed when FSA was used. This could
be attributed, in part, to the intraoperative diagnosis of 19
invasive cancers that went undetected in the preoperative
biopsy; in these cases, axillary staging could be directly
undertaken during the primary procedure. Both depart-
ments preferably used FSA in cases where the preoperative
biopsy detected invasive cancer only, resulting in differing
volumes between the FSA and the SR series (80 vs. 35
procedures).
Few other retrospective studies have evaluated the role
of FSA in intraoperative margin assessment in BCS
patients [16–18]. In one study, SR was used for most of the
nonpalpable lesions, and FSA was preferably applied for
palpable breast masses [16]. Of a total population of 264
patients, 29% with invasive cancer but only 9% of those
with DCIS who had initial positive/close margins were
rendered margin-negative by intraoperative analysis and
immediate reexcision. The present study yielded similar
numbers, although the aforementioned difference between
invasive cancer and DCIS was not observed. From a clin-
ical perspective, the type of carcinoma (invasive versus
DCIS) ultimately detected by permanent section analysis is
of no relevance to the surgeon’s decision about which
intraoperative analytic technique to use to determine mar-
gin status. By contrast, DCIS detected by the preoperative
biopsy is highly relevant to the surgeon. The present study
showed that, thanks to FSA, in 14 of the 47 instances
(29.8%) in which cytologic testing or a preoperative biopsy
was indicative of DCIS, a single operation sufficed to
render initially margin-positive patients margin-negative.
Despite the focus on nonpalpable breast lesions in the
present study, specificity, sensitivity, and diagnostic accu-
racy of FSA were almost identical in the Cabioglu et al.
study [16] and the present study (9.17%, 77.8%, and
Table 1 Baseline characteristics for 115 nonpalpable breast lesions, by intraoperative margin assessment technique (FSA vs. SR)
Frozen section analysis Specimen radiography p
Characteristic: No. % No. %
Procedures 80 100 35 100
Patients 78 33
Age (years), median, range 59.6 (33.9–86.4) 57.5 (42.8–80.0) 0.453
Mammographic lesionsa 74 92.5 34 97.1 0.328
Microcalcifications 48 60.0 28 80.0
Nodular masses 11 13.8 3 8.6
Other 14 17.5 3 8.6
Missing data 1 1.3 0 0
Sonographic lesionsb 6 7.5 1 2.9
Preoperative histology 63 78.8 30 85.7 \ 0.001
Invasive carcinoma 33 41.3 4 11.4
DCIS or ADH 21 26.3 25 71.4
Invasive carcinoma ? DCIS or ADH 9 11.3 1 2.9
Malignant cytology 17 21.3 5 14.3
DCIS: ductal carcinoma in situ; ADH: atypical ductal hyperplasia
a Lesions detected by mammography with or without sonography
b Lesions detected by sonography alone
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Table 2 Histopathological findings, tumor stages, treatment, and follow-up of 115 nonpalpable breast lesions by intraoperative margin
assessment techniques
Parameter Frozen section analysis Specimen radiography p
No. % No. %
Procedures (no.) 80 100 35 100
Histologic results of FSA
Invasive carcinoma 47 58.8 n/a
DCIS 13 16.3 n/a
Invasive carcinoma ? DCISa 14 17.5 n/a
Other 6 7.5 n/a
Final histologic results
Invasive carcinoma 31 38.8 5 14.3
DCISa 12 15 21 60
Invasive carcinoma ? DCISa 37 46.3 9 25.7 \0.001
Borderline lesions
Atypical ductal hyperplasia 6 7.5 4 11.4
Atypical lobular hyperplasia 4 5 3 8.6
Lobular carcinoma in situ 12 15 1 2.9 0.242
TNM staging
Primary tumor (T)
Tis 12 15 21 60
T1 60 75 14 40
T2 8 10 0 0 \0.001
Regional lymph nodes (N)
cN0 11 13.8 20 57.1
pN0 35 43.8 12 34.3
pN0(sn) 18 22.5 3 8.6
pN1mi 4 5 0 0
pN1 9 11.3 0 0
pN2 2 2.5 0 0
pN3 1 1.3 0 0 \0.001
Distant metastases (M)
M0 80 100 35 100
M1 0 0 0 0 1.000
Stage according to AJCC
0 12 15 21 60
I 50 62.5 14 40
IIA 9 11.3 0 0
IIB 6 7.5 0 0
IIIA 2 2.5 0 0
IIIB 0 0 0 0
IIIC 1 1.3 0 0 \0.001
Primary operation
BCT 70 87.5 35 100
Mastectomy 10 12.5 0 0 0.029
Primary axillary lymph node staging
Axillary lymph node dissectiona 47 58.8 3 8.6
Sentinel lymph node dissection alone 18 22.5 3 8.6
No axillary lymph node staging 15 18.8 29 82.9 \0.001
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87.4%, respectively, compared to 87.5%, 80.0%, and
83.8%, respectively). Moreover, in the present study the
FSA accuracy rates were similar (89.5%, 82.1%, and
85.1%, respectively) for the subgroup of procedures in
which DCIS or atypical ductal hyperplasia was suspected
based on preoperative histocytologic analysis. Another fact
of interest is that of 52 patients in the above study [16] for
whom permanent section analysis showed final positive/
close margins only 23 (44.2%) were subjected to a second
procedure to obtain wider negative margins, compared to
Table 2 continued
Parameter Frozen section analysis Specimen radiography p
No. % No. %
Complete long-term follow-up data sets 75 93.8 28 80.0
Follow-up (years), median, range 4.4 (0.1–14.1) 3.9 (0.3–8.0) 0.258
Recurrences 4 5.0 2 5.7 0.874
Deaths 6 7.5 0 0 0.096
n/a: not applicable; AJCC: American Joint Committee on Cancer; BCT: breast-conserving therapy
a With or without sentinel lymph node dissection
Table 3 Intraoperative margin assessment results, therapeutic impact, and accuracy rates after the first operation, by assessment technique (FSA
vs. SR)
Total study population (115 procedures) DCIS or ADH in preoperative biopsy (n = 78)
Parameter Margin with FSA
(n = 80)
Margin with SR
(n = 35)
Margin with FSA
(n = 47)
Margin with SR
(n = 31)
Negativea Positiveb Negativea Positiveb Negativea Positiveb Negativea Positiveb
No. % No. % No. % No. % No. % No. % No. % No. %
Intraoperative diagnosis by FSA or SR 43 53.8 37 46.3 17 48.6 18 51.4 22 46.8 25 53.2 15 48.4 16 51.6
Diagnosis by permanent section analysis 35 43.8 32 40.0 9 25.7 12 34.3 17 36.2 23 48.9 7 22.6 10 32.3
Positive margin turned into negative 0 0 22 27.5 0 0 5 14.3 0 0 14 29.8 0 0 4 12.9
Positive margin at the end of primary
operation
8 10 10 12.5 8 22.9 7 20.0 5 10.6 9 19.1 8 25.8 6 19.4
Diagnostic accuracy (%) 83.8 60.0 85.1 54.8
Sensitivity (%) 80.0 60.0 82.1 55.6
Specificity (%) 87.5 60.0 89.5 53.8
Negative predictive value (%) 81.4 52.9 77.3 46.7
Positive predictive value (%) 86.5 66.7 92.0 62.5
FSA: frozen section analysis; SR: specimen radiography
a Margin C1 mm free of tumor
b Margin involving tumor or \1 mm free of tumor
Table 4 Secondary operations performed in the FSAand SR series
Parameter Frozen section analysis Specimen radiography p
No. % No. %
Procedures (no.) 80 100 35 100
Frequency of secondary reexcision 10/80 12.5 13/35 37.1 0.002
Type of secondary operation
BCT 3 3.8 8 22.9
Mastectomy 7 8.8 5 14.3 0.133
Frequency of secondary axillary lymph node staging 4/80 5.0 9/35 25.7 0.001
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21 of the 33 (63.6%) such patients in the study reported
here. This is relevant inasmuch as it shows that not all
patients with positive/close margins after a first tumoral
excision undergo subsequent local reexcision.
Two other studies support the present findings to the
effect that FSA may be beneficial in most instances of BCS
[17, 18]. In one [18], the margins of specimens excised
from 97 BSC patients were evaluated using FSA. A total of
59% of the excisions were needle-localization guided,
whereas the diagnostic accuracy of FSA came to 84%. The
authors recommended FSA for BCS in general but con-
cluded that DCIS was more difficult to identify with FSA
given the significantly higher rates of false negatives found
in this group of patients. Finally, Camp et al. [17] retro-
spectively reviewed BCS in 220 patients with T1/2 early
invasive breast cancer and 47 patients with DCIS using
margins shaved intraoperatively for FSA. They concluded
that FSA could lower reexcision rates in similar propor-
tions in the two groups, but they did not distinguish
between palpable and nonpalpable lesions.
The eight false negatives returned by FSA merit some
comment. Freezing artifacts, a well known limitation of
FSA, may have been responsible in a few cases. Another
possible source, however, may have been sampling errors
in large specimens for which only a small number of gross
examination and surgeon references were available to the
pathologist. Sampling errors should be minimized by
cooperating closely with the pathologist, who should be
allowed, wherever possible, to focus on the margin closest
to the tumor.
The limitations of this study are acknowledged. Most
relevantly, as this is a retrospective study based on a review
of medical charts rather than a prospective randomized
trial, the two series of patients differed in terms of a
number of baseline variables. For instance, FSA was used
significantly more often than SR for invasive lesions
identified by preoperative biopsy/cytology, and significant
differences were observed between the tumor stages
recorded in the two series.
Second, partly due to the application of strict exclusion
criteria, this study covered only a small number of proce-
dures. Third, over the fairly long period studied, surgeons
may have modified the lumpectomy technique used in an
attempt to minimize secondary reexcisions and locore-
gional recurrence while maintaining suitable cosmesis.
Nonetheless, of the total 115 procedures, only 19 were
performed during the first half of the period. This distri-
bution may suggest the increasing effectiveness of
screening programs in detecting nonpalpable breast lesions
over the period studied or the growing use of intraoperative
margin assessment to treat these lesions; in any event, the
results reported here seem to reflect current surgical prac-
tice at Basel University Hospital.
Conclusions
Summarizing, FSA seems to be more accurate than SR for
intraoperative margin assessment during BCS for nonpal-
pable breast lesions, regardless of the histopathologic
nature of the lesion. FSA significantly reduces the number
of secondary reexcisions and secondary axillary lymph
node staging procedures. Due to the retrospective nature
and the small power of the evidence presented, these
findings must be corroborated by larger-scale prospective
studies.
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